Evidence map›Paper›PMID 32110546›Full record

ArticleAvicenna journal of medicine

Transcatheter aortic valve replacement in patients with bicuspid aortic valve stenosis: national trends and in-hospital outcomes.

Mohamad Soud, Yasser Al-Khadra, Fahed Darmoch, Homam Moussa Pacha, Zaher Fanari, M Chadi Alraies

Open access · diamondAbstract read
In one paragraph

Article in Avicenna journal of medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Mohamad SoudRutgers New Jersey Medical School, Newark, New Jersey, USA.
Yasser Al-KhadraCleveland Clinic, Medicine Institute, Cleveland, Ohio, USA.
Fahed DarmochBeth Israel Deaconess Medical center/Harvard medical school, Boston, Massachusetts, USA.
Homam Moussa PachaUniversity of Texas Health Science Center, McGovern Medical School, Houston, Texas, USA.
Zaher FanariWesley Medical Center, Wichita, KS, USA.
M Chadi AlraiesWayne State University, Detroit Medical Center, Detroit Heart Hospital, Detroit, Michigan, USA.
Cleveland Clinic · USDetroit Medical Center · USHarvard University · USRutgers New Jersey Medical SchoolThe University of Texas Health Science Center at Houston · USWesley Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBicuspid aortic valve (BAV) disease is considered the most common congenital heart disease and the main etiology of aortic valve stenosis (AS) in young adults. Although transcatheter aortic valve replacement (TAVR) is routinely used in high- and intermediate-risk patients with AS, BAV patients with AS were excluded from all pivotal trials that led to TAVR approval. We sought, therefore, to examine in-hospital outcomes of patients with BAV who underwent TAVR in comparison with surgical aortic valve replacement (SAVR).

methodsUsing the National Inpatient Sample from 2011 to 2014, we identified patients with BAV with International Classification of Diseases-Ninth Revision-CM code 746.4. Patients who underwent TAVR were identified using ICD-9 codes 35.05 and 35.06 and those who underwent SAVR were identified using codes 35.21 and 35.22 during the same period.

resultsA total of 37,052 patients were found to have BAV stenosis. Among them, 36,629 patients (98.8%) underwent SAVR, whereas 423 patients (1.14%) underwent TAVR. One-third of enrolled patients were female, and the majority of the patients were White with a mean age of 65.9 ± 15.1 years. TAVR use for BAV stenosis significantly increased from 0.39% in 2011 to 4.16% in 2014 (

conclusionThere is a steady increase in TAVR use for BAV stenosis patients along with a significant decrease in length of stay.

Indexed as

Bicuspid aortic valve stenosissurgical aortic valve replacementtranscatheter aortic valve replacement

Identifiers

PMID32110546
PMCPMC7014993
OpenAlexW3001045998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.